Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, presented 11 ...

An online pharmacokinetic calculation formula (Sawchuk-Zaske [6] method: one-compartment model) was added to the CPOE system to reduce inappropriate gentamicin dosages and subsequent adverse drug ...

Generated net FUROSCIX® revenue of $11.8 million in the first quarter of 2025 Formally launched FUROSCIX in second approved indication, Chronic Kidney Disease, in April 2025 Autoinjector on track for ...

If you currently have eye drops in your medicine cabinet, make sure they're not part of a recent recall. Plus, how to buy ...

A multidisciplinary, multi-organizational panel of experts in medical oncology, dermatology, gastroenterology, rheumatology, pulmonology, endocrinology, urology ...

In today's world of social platforms and the general explosion of digital media and constant content creation, adverse media screening has become increasingly relevant for financial institutions, ...

2010;67(4):274-279. The objectives of this study were to develop and test an adjustment factor (AF) for estimating aminoglycoside clearance (CL amino) from the Cockcroft–Gault equation in ...

Here, we describe studies of the aminoglycoside-mediated suppression of premature stop codons. This therapeutic approach is attractive for Rett syndrome, because it circumvents the problems ...

the tetracylines and the aminoglycosides. A separate track is represented by the discovery that aromatic sulfa scaffolds originally from the chemical dyes industry frameworks had antibiotic activity.

The term "adverse childhood experience" refers to a range of negative situations a child may face or witness while growing up. These experiences include emotional, physical, or sexual abuse ...

-ARIKAYCE ® (amikacin liposome inhalation suspension) Total Revenue of $92.8 Million for the First Quarter of 2025, Reflecting 23% Growth Over the First Quarter of 2024- -NDA for Brensocatib in ...

Michael Bolton is opening up about his cancer battle for the first time. The music icon, 72, explained in an interview with People published Wednesday how he’s continued to fight to survive ...